Acutaas Chemicals Limited

Acutaas Chemicals Files Certificate Under SEBI Regulations for Q3FY26

Acutaas Chemicals Limited has filed a certificate for the quarter ended December 31, 2025, under SEBI regulations. The registrar confirmed no dematerialisation requests were processed during the quarter, meaning no share certificates were altered or replaced.

Acutaas Chemicals Limited Closes Trading Window from Jan 1, 2026 for Q3 Results

Acutaas Chemicals Limited will close its trading window from January 1, 2026, to consider Q3 FY26 unaudited financial results. The window will reopen 48 hours after the results declaration. The board meeting date for approving results will be announced later.

CARE Ratings reaffirms Acutaas Chemicals' long/short term bank facilities ratings

CARE Ratings reaffirms Acutaas Chemicals' long/short term bank facilities ratings at CARE A+; Stable / CARE A1+ for ₹135 crore (enhanced from ₹125 crore).

Acutaas Chemicals Limited announces schedule of investor conference meets in November 2025

Acutaas Chemicals Limited will attend Avendus Spark INDX, Kotak Midcap Conference, and JM Financial India Conference in November 2025 for investor meetings in Mumbai.

Acutaas Chemicals Announces Q2 & H1 FY26 Earnings Call Transcript

Acutaas Chemicals Limited released the transcript of its earnings call held on 17 October 2025, post the announcement of Q2 & H1 FY26 financial results.

Acutaas Chemicals Reports Increased Q2 FY25 EPS Despite Lower Total Income

Acutaas Chemicals announced Q2 and half-year FY25 unaudited financial results, showing basic EPS increased to ₹8.84 (standalone) and ₹8.90 (consolidated) for the quarter, despite a decrease in total income.

Acutaas Chemicals Limited announces availability of Earnings Call recording

Acutaas Chemicals Limited announced the recording of its Earnings Call, held on October 17, 2025, is now available on the company website for investor access.

Acutaas Chemicals Limited reports Q2 FY26 results with 24.1% YoY Revenue Growth

Acutaas Chemicals Limited announced Q2 FY26 results with revenue up 24.1% YoY to ₹3,062 million and EBITDA margin at 31.1%. The company anticipates around 25% revenue growth for the full year.

Acutaas Chemicals Investor Presentation on Q2 & H1 FY26 Results

Acutaas Chemicals releases investor presentation on Q2 & H1 FY26 results, reporting revenue of ₹3,062 million (₹306.2 crore), EBITDA of ₹953 million (₹95.3 crore) and PAT of ₹719 million (₹71.9 crore).

Acutaas Chemicals Reports Robust Q2 & Half-Year Results, Announces Strategic Investments

Acutaas Chemicals reported strong Q2 and half-year financial results, with significant growth in revenue and profit. The company also announced strategic investments in its subsidiary and a new joint venture.

Acutaas Chemicals Limited announces Earnings Conference Call on Oct 17, 2025

Acutaas Chemicals Limited will hold an earnings conference call on October 17, 2025, at 3:30 P.M. IST to discuss the financial results for the second quarter and half year ended on September 30, 2025.

Voting Results of 18th AGM: All Resolutions Passed with Requisite Majority

Acutaas Chemicals sets September 18, 2025 as record date for final dividend

Acutaas Chemicals Board Approves Key Director Re-appointments and 18th AGM

Acutaas Chemicals achieves EcoVadis Platinum Medal for Sustainability, ranking in top 1% globally

Acutaas Chemicals Launches 'Saksham Niveshak' Campaign for Shareholder KYC and Dividend Claims

Acutaas Chemicals to host investor/analyst plant visit on Sep 8, 2025

Acutaas Chemicals Reports Robust Q1 FY26 Results, Strategic Expansion into Semiconductor Chemicals via South Korea JV

Acutaas Chemicals Announces Unaudited Financial Results for Q1 Ended June 30, 2025

Acutaas Chemicals: VP - Strategy Designated as Senior Management Person; ESOS Adjusted Post-Stock Split

Acutaas Chemicals reports no deviation in preferential issue proceeds utilization

Acutaas Chemicals Reports Strong Q1 FY26 with 17.3% Revenue Growth

Acutaas Chemicals Reports Robust Q1 FY26 Results, PAT up 200%; Announces Key Strategic Investments & JV

Wholly Owned Subsidiary Name Change: Ami Organics Electrolytes to Acutaas Chemicals Electrolytes

Acutaas Chemicals to Host Q1FY26 Earnings Conference Call on July 30, 2025

Acutaas Chemicals to Invest up to ₹199.99 Crore in Wholly-Owned Subsidiary for Semiconductor Chemical Expansion